IL18 and inflammatory bowel disease: However, the pivotal role of this receptor subtype in driving IL-1β and IL-18 release, and other pro-inflammatory cytokines in gut tissue of IBD patients [15, 16], leads us to hypothesize a significant role of P2X4 in the pathophysiology of IBD.